🇺🇸 Aripiprzole in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Aggression — 1 report (10%)
  2. Agitation — 1 report (10%)
  3. Asthenia — 1 report (10%)
  4. Blood Creatine Phosphokinase Increased — 1 report (10%)
  5. Delusion Of Grandeur — 1 report (10%)
  6. Drug Interaction — 1 report (10%)
  7. Drug Level Above Therapeutic — 1 report (10%)
  8. Mood Swings — 1 report (10%)
  9. Myoglobin Blood Increased — 1 report (10%)
  10. Neuroleptic Malignant Syndrome — 1 report (10%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Aripiprzole approved in United States?

Aripiprzole does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Aripiprzole in United States?

New Mexico VA Healthcare System is the originator. The local marketing authorisation holder may differ — check the official source linked above.